These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25399769)

  • 21. Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.
    Cutellè C; Rastelli E; Gibellini M; Greco G; Frezza E; Botta A; Terracciano C; Massa R
    Neuromuscul Disord; 2018 Nov; 28(11):947-951. PubMed ID: 30270126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1.
    Knak KL; Sheikh AM; Andersen H; Witting N; Vissing J
    Neurology; 2020 Jun; 94(24):e2508-e2520. PubMed ID: 32457208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-Rater Reliability and Concurrent Validity of Quantified Muscle Testing for Maximal Knee Extensors Strength in Men with Myotonic Dystrophy Type 1.
    Roussel MP; Hébert LJ; Duchesne E
    J Neuromuscul Dis; 2019; 6(2):233-240. PubMed ID: 31127731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explanatory factors of dynamic balance impairment in myotonic dystrophy type 1.
    Bélair N; Côté I; Gagnon C; Mathieu J; Duchesne E
    Muscle Nerve; 2022 Jun; 65(6):683-687. PubMed ID: 35212003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1.
    Boentert M; Cao M; Mass D; De Mattia E; Falcier E; Goncalves M; Holland V; Katz SL; Orlikowski D; Sannicolò G; Wijkstra P; Hellerstein L; Sansone VA
    Respiration; 2020; 99(4):360-368. PubMed ID: 32299079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paving the way for a better understanding of the pathophysiology of gait impairment in myotonic dystrophy: a pilot study focusing on muscle networks.
    Naro A; Portaro S; Milardi D; Billeri L; Leo A; Militi D; Bramanti P; Calabrò RS
    J Neuroeng Rehabil; 2019 Sep; 16(1):116. PubMed ID: 31533780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal physical profile assessment of skeletal muscle manifestations in myotonic dystrophy.
    Nitz JC; Burns YR; Jackson RV
    Clin Rehabil; 1999 Feb; 13(1):64-73. PubMed ID: 10327099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responsiveness of outcome measures in myotonic dystrophy type 1.
    Knak KL; Sheikh AM; Witting N; Vissing J
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1382-1391. PubMed ID: 32672404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1.
    Roussel MP; Hébert LJ; Duchesne E
    Neuromuscul Disord; 2020 Apr; 30(4):283-293. PubMed ID: 32340814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.
    De Antonio M; Dogan C; Hamroun D; Mati M; Zerrouki S; Eymard B; Katsahian S; Bassez G;
    Rev Neurol (Paris); 2016 Oct; 172(10):572-580. PubMed ID: 27665240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
    Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
    J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: a five-year prospective cohort study.
    Hammarén E; Kjellby-Wendt G; Lindberg C
    Neuromuscul Disord; 2015 Feb; 25(2):141-8. PubMed ID: 25475393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.
    Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG
    Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1.
    Kierkegaard M; Petitclerc E; Hébert LJ; Gagnon C
    Neuromuscul Disord; 2017 Feb; 27(2):153-158. PubMed ID: 28062219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.
    Tarnopolsky M; Mahoney D; Thompson T; Naylor H; Doherty TJ
    Muscle Nerve; 2004 Jan; 29(1):51-8. PubMed ID: 14694498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower limb muscle magnetic resonance imaging in Chinese patients with myotonic dystrophy type 1.
    Song J; Fu J; Ma M; Pang M; Li G; Gao L; Zhang J
    Neurol Res; 2020 Feb; 42(2):170-177. PubMed ID: 31951783
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuromuscular transmission abnormalities in myotonic dystrophy type 1: A neurophysiological study.
    Bombelli F; Lispi L; Porrini SC; Giacanelli M; Terracciano C; Massa R; Petrucci A
    Clin Neurol Neurosurg; 2016 Nov; 150():84-88. PubMed ID: 27611986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myotonic dystrophy health index: Correlations with clinical tests and patient function.
    Heatwole C; Bode R; Johnson NE; Dekdebrun J; Dilek N; Eichinger K; Hilbert JE; Logigian E; Luebbe E; Martens W; Mcdermott MP; Pandya S; Puwanant A; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley RT
    Muscle Nerve; 2016 Feb; 53(2):183-90. PubMed ID: 26044513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.